Yellow fever vaccination: is one dose always enough?

Area of Science:

• Immunology
• Public Health
• Travel Medicine

Background:

• The World Health Organization (WHO) convened the Strategic Advisory Group of Experts on Immunisation (SAGE) in March 2013 to revise the 2003 Yellow Fever (YF) Position Paper.
• Discussions focused on updating guidelines regarding YF vaccination efficacy and duration of immunity.

Purpose of the Study:

• To review the WHO's updated guidance on yellow fever vaccination.
• To analyze the implications of the new recommendation that a single YF vaccine dose confers lifelong protection.
• To examine the discrepancy between the updated clinical guidance and existing International Health Regulations (IHR) 2005.

Main Methods:

• Review of the WHO's March 2013 SAGE meeting conclusions.
• Analysis of the evidence base supporting the updated YF vaccine recommendations.
• Examination of the International Health Regulations (IHR) 2005 concerning YF vaccination.

Main Results:

• The WHO SAGE concluded that a single dose of yellow fever vaccine provides lifelong protection.
• A booster dose of the YF vaccine is deemed unnecessary for maintaining immunity.
• The WHO's announcement has not led to immediate changes in the International Health Regulations (IHR) 2005.

Conclusions:

• The updated WHO guidance on YF vaccination suggests lifelong immunity from a single dose.
• A significant gap exists between current medical understanding and legal requirements under the IHR 2005.
• This discrepancy presents challenges for healthcare professionals, international travelers, and the travel industry in navigating YF vaccine protocols.